Dr Lawrence Kim is a urologist at Westmead Hospital with extensive uro-oncology training, including a fellowship at the Royal Marsden. He leads clinical research recognised nationally and internationally, co-directs Westmead Urology Research, and directs the Uro-oncology Unit within the Master of Surgery program at the University of Sydney.

Kindly sponsored by


Dr Ryan J Nelson, a lead urologist in Michigan, United States, specialises in robotic surgery using the da Vinci SP system. His expertise includes various urological cancers (prostate, bladder, ureteral, kidney, testicular), erectile dysfunction, low testosterone, and scrotal masses. A world leader in robotic single port surgery, Dr Nelson has published extensively on urologic tumours, single robotic partial nephrectomy, and robotic cystectomy. Dr Nelson received his Doctor of Osteopathic Medicine degree from Touro School of Osteopathic Medicine in Vallejo, California. Dr Nelson completed his surgical residency at Michigan State – St. John Macomb/Oakland Hospital and his urologic residency at Michigan State – McLaren Macomb Hospital in 2015. He also completed a two-year Urologic Robotic and Minimally Invasive Fellowship at the Cleveland Clinic, which allowed a foundation, second to none, for his advancement in robotic surgery. Dr Nelson specialises in difficult robotic cases with the single port robot instead of the multiport robot, such as creating new bladders, robotic reconstruction of ureters, and nephron sparing surgery for complex kidney tumours.

Professor Henk van der Poel is head of the department of urology at the Netherlands Cancer Center in Amsterdam (NL) and endowed-professor the Free-University, Amsterdam (NL). Main focuses of research are the role of image-guided surgery in the management of urological oncological diseases and the perioperative network cancer-care for prostate cancer. He is editor-in-chief of the Dutch Journal of Urology.

Kindly sponsored by


Dr. Youness Ahallal is a leading urologist and robotic surgeon based in Casablanca, Morocco. With extensive training in New York and France, he specializes in advanced robotic and minimally invasive surgery. Dr. Ahallal is a pioneer in the field, having performed a world-first telesurgery operation from Shanghai to Casablanca. Committed to innovation, he actively promotes the development of robotic surgery and telemedicine across Morocco and Africa. A sought-after speaker, he shares insights on the future of digital health and medical technology. Dr. Ahallal’s work bridges cutting-edge technology with patient care, shaping the future of surgery in the region.

Kindly sponsored by


Dr. Youness Ahallal is a leading urologist and robotic surgeon based in Casablanca, Morocco. With extensive training in New York and France, he specializes in advanced robotic and minimally invasive surgery. Dr. Ahallal is a pioneer in the field, having performed a world-first telesurgery operation from Shanghai to Casablanca. Committed to innovation, he actively promotes the development of robotic surgery and telemedicine across Morocco and Africa. A sought-after speaker, he shares insights on the future of digital health and medical technology. Dr. Ahallal’s work bridges cutting-edge technology with patient care, shaping the future of surgery in the region.

Professor. Rafael Ferreira Coelho is a distinguished urologist. He received his medical degree from the University of São Paulo (USP), and has been studying the benefits of robotic surgery in the treatment of diseases of the male urogenital system, especially cancer. Dr. Coelho is a member of the Brazilian Society of Urology and the Fellowship in Robotic Urology, and also a member of the clinical staff of Hospitals Sírio Libanês, Albert Einstein and Hospital Nove de Julho. He has also served as Director of Research at the Global Robotics Institute – Florida Hospital Celebration Health, Instructor of Urology at University of Central Florida School of Medicine, Medical Coordinator of the Urological Clinic Cancer Institute of the State of São Paulo ICESP/FMUSP, and Head of the prostate cancer group at the Brazilian Society of Urology.

A/Prof Scott Leslie is a robotic surgery specialist, treating urological cancers with a focus on oncological outcomes and functional results. Dr Leslie trained in robotic surgery at the University of Southern California (USC), Los Angeles and is the robotic surgery lead at the University of Sydney.

David F. Penson, MD, MPH is the Hamilton and Howd Chair in Urologic Oncology, Director of the Center for Surgical Quality and Outcomes Research and Professor and Chair, Department of Urology at Vanderbilt University Medical Center. He obtained his MD from Boston University and completed his urology residency at UCLA Medical Center in Los Angeles. He then was awarded a Robert Wood Johnson Clinical Scholar fellowship at Yale University and also obtained an MPH at Yale. He currently maintains a clinical practice in urologic oncology at the Vanderbilt-Ingram Cancer Center. His specific research interests include the comparative effectiveness of treatment options in localized prostate cancer and the impact of the disease and its treatment on patients’ quality of life. He has received federal grant funding from the National Cancer Institute, the US Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention and the Patient-Centered Outcomes Research Institute. His work has been published in various high-profile journals, including the New England Journal of Medicine, JAMA and the Annals of Internal Medicine. He previously chaired the National Institutes of Health’s Health Services Outcomes and Delivery (HSOD) study section, which reviews almost all health services research grant submitted to the NIH. He also maintains a strong interest in health policy and quality improvement. He currently serves as the Secretary of the American Urological Association.

Dr Juliette Cotte is a French urologist currently completing a robotic surgery fellowship at the Institute of Academic Surgery at Royal Prince Alfred Hospital in Sydney. She trained at Sorbonne University in Paris, specialising in urology with a strong focus on minimally invasive and oncological surgery. Prior to her current position, Dr Cotte completed a fellowship in both neuro-urology and urologic oncology at Pitié Salpêtrière Hospital in Paris, where she also received training in robotic surgery.

Phil Dundee is a urologist with specialist expertise in robotic and laparoscopic surgery. After completing his general urology training in Melbourne, he undertook fellowship training in laparoscopic surgery at The Royal Surrey County Hospital, followed by a year of robotic training at Guy’s and St Thomas’ Hospital. Since returning to Melbourne at the end of 2012, Phil has established the first robotic cystectomy surgery program in Melbourne and leads the Robotic Surgery Fellowship program at The Royal Melbourne Hospital. He has been an invited speaker and faculty member at national and international robotic surgery workshops and received the Peter J Dohrmann medal from the Epworth Hospital in 2018 for research in robotic surgery.

Kindly sponsored by


Prof. Tobias Maurer, FEBU, is a renowned urologist at the Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, with a clinical and scientific focus on prostate cancer, particularly in the fields of imaging, surgery, and medical therapy. He is a leading expert in PSMA-PET imaging and PSMA-radioguided surgery, with over 285 scientific publications and an h-index of 62. Prof. Maurer has served as principal or co-investigator in more than 30 clinical trials and has received over 30 national and international awards, including the DGU Research and Innovation Award for PSMA-radioguided surgery.

Kindly sponsored by


A/Professor James Porter, is Director of Robotic Surgery for Providence St. Joseph Health and Swedish Medical Center. He is the most experienced robotic surgeon in the Pacific Northwest and has performed over 5000 robotic procedures. He is Director of the Robotic and Laparoscopic Fellowship in Urology at Swedish Medical Center over the last 22 years. He is recognized as a national and international leader in robotic surgery and is active in teaching robotic surgical techniques to surgeons around the globe. He pioneered the retroperitoneal approach for robotic renal surgery as well as retroperitoneal lymph node dissection for the treatment of testicular cancer.

Kindly sponsored by


A/Professor James Porter, is Director of Robotic Surgery for Providence St. Joseph Health and Swedish Medical Center. He is the most experienced robotic surgeon in the Pacific Northwest and has performed over 5000 robotic procedures. He is Director of the Robotic and Laparoscopic Fellowship in Urology at Swedish Medical Center over the last 22 years. He is recognized as a national and international leader in robotic surgery and is active in teaching robotic surgical techniques to surgeons around the globe. He pioneered the retroperitoneal approach for robotic renal surgery as well as retroperitoneal lymph node dissection for the treatment of testicular cancer.

Dr. Reiter is the Bing Professor of Urologic Oncology and Chief of the Division of Urologic Oncology. He attended Stanford Medical School, completed his urologic training at Stanford and Baylor College of Medicine, and completed additional fellowship training in urological cancer at the National Cancer Institute. Dr. Reiter was awarded the Outstanding Achievement Award by the Urologic Oncology branch of the National Cancer Institute. Dr. Reiter is an internationally recognized expert in all areas of prostate cancer management and research. He was among the first to integrate functional MRI imaging and PSMA PET imaging into the diagnosis, surgical management, and care of men with prostate cancer. He was also an early innovator in the field of robotic surgery, and has completed more than 2,500 robotic prostatectomies. In addition to surgical management of prostate cancer, Dr. Reiter has expertise in MRI-guided biopsies to diagnose prostate cancer, focal therapy to treat select individuals, as well as all forms of medical therapy. Dr. Reiter has a particular interest in the multidisciplinary management of men with high-risk prostate cancer, incorporating the latest in genomics, clinical trials, and precision medical therapies into treatment plans in collaboration with UCLA leaders in the areas of radiation, medical and nuclear prostate oncology. In addition to his broad clinical interests in prostate cancer, Dr. Reiter is a leading researcher in prostate cancer and has led UCLA’s 12 million SPORE grant, which supports work to translate laboratory discoveries into clinical advances, for more than 15 years. Drugs such as enzalutamide and apalutamide, and imaging tools such as PSMA PET, are among the many advances that have emanated from this program. His own laboratory discovered the prostate stem cell antigen and developed antibodies to target this protein, which has led to novel imaging and therapeutic approaches for prostate cancer currently in clinical trials. Dr. Reiter has authored more than 250 papers and lectures nationally and internationally on all aspects of clinical care of men with prostate cancer.